| pubmed-article:10510682 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0262926 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0332119 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0206056 | lld:lifeskim |
| pubmed-article:10510682 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:10510682 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10510682 | pubmed:dateCreated | 1999-11-24 | lld:pubmed |
| pubmed-article:10510682 | pubmed:abstractText | The pharmacokinetics of free L-dopa in blood and tissue of five parkinsonian patients with malignant melanoma was studied with microdialysis. In one case the effect of L-dopa treatment on 5-S-cysteinyldopa and the melanoma was studied. Gastric emptying and its effects on free L-dopa in blood were also investigated in one of the patients. | lld:pubmed |
| pubmed-article:10510682 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10510682 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10510682 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10510682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10510682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10510682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10510682 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10510682 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10510682 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:LjungdahlAA | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:OlssonJ EJE | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:KågedalBB | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:HannestadUU | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:GranérusA KAK | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:DizdarNN | lld:pubmed |
| pubmed-article:10510682 | pubmed:author | pubmed-author:KullmanAA | lld:pubmed |
| pubmed-article:10510682 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10510682 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:10510682 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10510682 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10510682 | pubmed:pagination | 231-7 | lld:pubmed |
| pubmed-article:10510682 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:meshHeading | pubmed-meshheading:10510682... | lld:pubmed |
| pubmed-article:10510682 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10510682 | pubmed:articleTitle | L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma. | lld:pubmed |
| pubmed-article:10510682 | pubmed:affiliation | Department of Clinical Chemistry, University Hospital, Linköping, Sweden. | lld:pubmed |
| pubmed-article:10510682 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10510682 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
